AtriCure Receives CE-Mark for the EnCompass® Clamp

Approval provides new catalyst for AtriCure’s international growth MASON, Ohio --(BUSINESS WIRE)--Oct. 1, 2024-- AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain